These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 2536323

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.
    Srkalovic G, Bokser L, Radulovic S, Korkut E, Schally AV.
    Endocrinology; 1990 Dec; 127(6):3052-60. PubMed ID: 2174343
    [Abstract] [Full Text] [Related]

  • 3. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
    Pinski J, Lamharzi N, Halmos G, Groot K, Jungwirth A, Vadillo-Buenfil M, Kakar SS, Schally AV.
    Endocrinology; 1996 Aug; 137(8):3430-6. PubMed ID: 8754771
    [Abstract] [Full Text] [Related]

  • 4. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer.
    Fekete M, Wittliff JL, Schally AV.
    J Clin Lab Anal; 1989 Aug; 3(3):137-47. PubMed ID: 2569034
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines.
    Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, Hölzel F, Schulz KD, Schally AV.
    Cancer Res; 1993 Nov 15; 53(22):5439-46. PubMed ID: 8221683
    [Abstract] [Full Text] [Related]

  • 9. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.
    Segal-Abramson T, Kitroser H, Levy J, Schally AV, Sharoni Y.
    Proc Natl Acad Sci U S A; 1992 Mar 15; 89(6):2336-9. PubMed ID: 1312718
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of binding of cytotoxic analogs of luteinizing hormone-releasing hormone to human breast cancer and mouse MXT mammary tumor.
    Milovanovic SR, Radulovic S, Schally AV.
    Breast Cancer Res Treat; 1992 Mar 15; 24(2):147-58. PubMed ID: 8443402
    [Abstract] [Full Text] [Related]

  • 11. Decreased ability of old male rats to secrete luteinizing hormone (LH) is not due to alterations in pituitary LH-releasing hormone receptors.
    Sonntag WE, Forman LJ, Fiori JM, Hylka VW, Meites J.
    Endocrinology; 1984 May 15; 114(5):1657-64. PubMed ID: 6325129
    [Abstract] [Full Text] [Related]

  • 12. Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function.
    Marchetti B, Guarcello V, Morale MC, Bartoloni G, Farinella Z, Cordaro S, Scapagnini U.
    Endocrinology; 1989 Aug 15; 125(2):1025-36. PubMed ID: 2546732
    [Abstract] [Full Text] [Related]

  • 13. Antagonists of luteinizing hormone releasing hormone bind to rat mast cells and induce histamine release.
    Sundaram K, Didolkar A, Thau R, Chaudhuri M, Schmidt F.
    Agents Actions; 1988 Dec 15; 25(3-4):307-13. PubMed ID: 2464275
    [Abstract] [Full Text] [Related]

  • 14. Effect of treatment with LHRH analogs containing cytotoxic radicals on the binding characteristics of receptors for luteinizing-hormone-releasing hormone in MXT mouse mammary carcinoma.
    Milovanovic SR, Monje E, Szepeshazi K, Radulovic S, Schally A.
    J Cancer Res Clin Oncol; 1993 Dec 15; 119(5):273-8. PubMed ID: 8382705
    [Abstract] [Full Text] [Related]

  • 15. Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties.
    Janáky T, Juhász A, Rékási Z, Serfözö P, Pinski J, Bokser L, Srkalovic G, Milovanovic S, Redding TW, Halmos G.
    Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10203-7. PubMed ID: 1332035
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of luteinizing hormone-releasing hormone receptor binding in rat pituitary cell monolayer cultures; influence of intercellular communication.
    Andries M, Denef C.
    Mol Cell Endocrinol; 1986 Feb 01; 44(2):147-58. PubMed ID: 3005085
    [Abstract] [Full Text] [Related]

  • 19. Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma.
    Srkalovic G, Wittliff JL, Schally AV.
    Cancer Res; 1990 Mar 15; 50(6):1841-6. PubMed ID: 2155060
    [Abstract] [Full Text] [Related]

  • 20. Targeted chemotherapy for triple-negative breast cancers via LHRH receptor.
    Föst C, Duwe F, Hellriegel M, Schweyer S, Emons G, Gründker C.
    Oncol Rep; 2011 May 15; 25(5):1481-7. PubMed ID: 21331448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.